<DOC>
	<DOCNO>NCT00393822</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety , tolerability palifermin ( recombinant human keratinocyte growth factor , rHuKGF ) reduce incidence oral mucositis subject stage 2B 3 locally advanced , colon cancer receive chemotherapy adjuvant treatment disease .</brief_summary>
	<brief_title>A Study Palifermin Reduction Oral Mucositis Subjects With Stage 2B 3 Locally Advanced , Colon Cancer</brief_title>
	<detailed_description>This study conduct determine whether administration single IV dose palifermin 3 day initiation chemotherapy 3 day subsequent treatment cycle would reduce incidence oral mucositis evaluate safety profile subject population . This study evaluate efficacy palifermin reduce incidence grade ≥ 2 OM subject stage 2B stage 3 locally advanced , colon cancer undergo adjuvant chemotherapy 5-FU leucovorin cycle 1 . This study also assess safety tolerability palifermin administer single IV dose cycle 5-FU leucovorin , evaluate effect palifermin patient-reported mouth throat soreness , incidence grade ≥ 2 oral mucositis cycle 2 , duration grade ≥ 2 oral mucositis , 5-FU dose reductions/delays long-term effect palifermin disease outcome survival .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>History newly diagnose histologically confirm resect colon cancer ( American Joint Committee Cancer [ AJCC ] Stage 2B 3 ) candidate adjuvant 5FU Leucovorin Eastern Cooperative Oncology Group performance status ≤ 1 Functional hematopoietic hepatorenal system Previous therapy ( e.g . chemotherapy , radiotherapy biological therapy ) colon cancer , surgical tumor resection Presence history primary malignancy Presence active chronic oral mucositis xerostomia Previous treatment keratinocyte growth factor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>KGF</keyword>
	<keyword>Palifermin</keyword>
	<keyword>Oral Mucositis</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Amgen</keyword>
	<keyword>Oncology</keyword>
	<keyword>Colon Cancer</keyword>
</DOC>